ArticleGynecologic oncology2023

Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.

Blair McNamara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.